[Deprecated] COVID-19 HSE Weekly Booster Vaccination Figures

Theme: Health
Views: 0
Openness rating:

Please see FAQ for latest information on COVID-19 Data Hub Data Flows   https://covid-19.geohive.ie/pages/helpfaqs Category Field label Field Name Explanation

ExtractDate Extract Date Date the data is Extracted

Latitude Latitude

Longitude Longitude

Week Vaccination Date Date the Vaccination occurred

WeeklyBoosterVaccines Weekly Booster Vaccinations Includes Additonal Dose and Immunocompromised Dose only

Gender Male

Gender Female

Gender NA

Vaccine Brand - Dose Number AD_Pfizer First Booster Dose of Pfizer 

Vaccine Brand - Dose Number AD_Moderna First Booster of Moderna

Vaccine Brand - Dose Number AD_AstraZeneca First Booster of AstraZeneca

Vaccine Brand - Dose Number AD_Janssen First Booster of Janssen 

Vaccine Brand - Dose Number ID_Pfizer Immunocompromised Dose of Pfizer

Vaccine Brand - Dose Number ID_Moderna Immunocompromised Dose of Moderna

Vaccine Brand - Dose Number ID_AstraZeneca Immunocompromised Dose of Astrazeneca

Vaccine Brand - Dose Number ID_Janssen Immunocompromised Dose of Janssen

Age Group AD_Age0to9 A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_Age10to19 A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_Age20to29 A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_Age30to39 A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_Age40to49 A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_Age50to59 A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_Age60to69 A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_Age70to79 A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_Age80+ A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group AD_NA A First Booster of a Vaccine  First Booster Dose of an Astrazenenca or MRNA 

Age Group Cumulative AD_Age0to9_Cum Cumulative Age 5 to 11 Cumulative First Booster Dose Age  0 to 9

Age Group Cumulative AD_Age10to19_Cum Cumulative  Age 12 to 19 Cumulative First Booster Dose Age  10 to 19

Age Group Cumulative AD_Age20to29_Cum Cumulative Age 20 to 29 Cumulative First Booster Dose Age 20 to 29

Age Group Cumulative AD_Age30to39_Cum Cumulative Age 30 to 39 Cumulative First Booster Dose Age  30 to 39

Age Group Cumulative AD_Age40to49_Cum Cumulative Age 40 to 49 Cumulative First Booster Dose Age 40 to 49

Age Group Cumulative AD_Age50to59_Cum Cumulative Age50 to 59 Cumulative First Booster Dose Age  50 to 59

Age Group Cumulative AD_Age60to69_Cum Cumulative Age 60 to 69 Cumulative First Booster Dose Age  60 to 69

Age Group Cumulative AD_Age70to79_Cum Cumulative Age 70 to 79 Cumulative First Booster Dose Age  70 to 79

Age Group Cumulative AD_Age80+_Cum Cumulative Age 80+ Cumulative First Booster Dose Age  80+

Age Group Cumulative AD_NA_Cum Cumulative Age Not Assigned Cumulative First Booster Dose Age  Not Assigned

Age Group Cumulative Percent ADPer_Age0to9 First Booster Dose Percent  Age 5 to 11 Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_Age10to19 First Booster Dose Percent  Age 12 to 19 Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_Age20to29 First Booster Dose Percent  Age 20 to 29 Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_Age30to39 First Booster Dose Percent  Age 30 to 39 Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_Age40to49 First Booster Dose Percent  Age 40 to 49 Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_Age50to59 First Booster Dose Percent  Age 50 to 59 Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_Age60to69 First Booster Dose Percent  Age 60 to 69 Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_Age70to79 First Booster Dose Percent  Age 70 to 79 Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_Age80+ First Booster Dose Percent  80+ Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group Cumulative Percent ADPer_NA First Booster Dose Percent  Not Assigned Cumulative First Booster Dose Age cohort/ Age cohort population

Age Group ID_Age0to9 Immunocompromised Dose Age 5 to 11 Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group ID_Age10to19 Immunocompromised Dose Age 12 to 19 Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group ID_Age20to29 Immunocompromised Dose Age 20 to 29 Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group ID_Age30to39 Immunocompromised Dose Age 30 to 39 Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group ID_Age40to49 Immunocompromised Dose Age 40 to 49 Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group ID_Age50to59 Immunocompromised Dose Age 50 to 59 Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group ID_Age60to69 Immunocompromised Dose Age 60 to 69 Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group ID_Age70to79 Immunocompromised Dose Age 70 to 79 Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group ID_Age80+ Immunocompromised Dose Age 80+ Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group Cumulative ID_NA Immunocompromised Dose Age Not Available Immunocompromised Dose of an MRNA or AztraZeneca Vaccine

Age Group Cumulative ID_Age0to9_Cum Cumulative Immunocompromised Dose Age 12 to 19

Age Group Cumulative ID_Age10to19_Cum Cumulative Immunocompromised Dose Age 10 to 19

Age Group Cumulative ID_Age20to29_Cum Cumulative Immunocompromised Dose Age 20 to 29

Age Group Cumulative ID_Age30to39_Cum Cumulative Immunocompromised Dose Age 30 to 39

Age Group Cumulative ID_Age40to49_Cum Cumulative Immunocompromised Dose Age 40 to 49

Age Group Cumulative ID_Age50to59_Cum Cumulative Immunocompromised Dose Age 50 to 59

Age Group Cumulative ID_Age60to69_Cum Cumulative Immunocompromised Dose Age 60 to 69

Age Group Cumulative ID_Age70to79_Cum Cumulative Immunocompromised Dose Age 70 to 79

Age Group Cumulative ID_Age80+_Cum Cumulative Immunocompromised Dose Age 80+

Age Group Cumulative ID_NA_Cum Cumulative Immunocompromised Dose Age Not Available

WeeklyAdditionalDose2 Weekly Second Booster Vaccinations Includes 2nd Booster Doses only

AD2_Age05to11 A Second Booster Dose of a Vaccine Age 5 to 11

AD2_Age12to19 A Second Booster Dose of a Vaccine Age 12 to 19

AD2_Age20to29 A Second Booster Dose of a Vaccine Age 20 to 29

AD2_Age30to39 A Second Booster Dose of a Vaccine Age 30 to 39

AD2_Age40to49 A Second Booster Dose of a Vaccine Age 40 to 49

AD2_Age50to59 A Second Booster Dose of a Vaccine Age 50 to 59

AD2_Age60to69 A Second Booster Dose of a Vaccine Age 60 to 69

AD2_Age70to79 A Second Booster Dose of a Vaccine Age 70 to 79

AD2_Age80+ A Second Booster Dose of a Vaccine Age 80+

AD2_NA A Second Booster Dose of a Vaccine Age Not assigned

AD2_Age05to11_Cum Cumulative Second Booster Dose Age 5 to 11

AD2_Age12to19_Cum Cumulative Second Booster Dose  Age 12 to 19

AD2_Age20to29_Cum Cumulative Second Booster Dose Age 20 to 29

AD2_Age30to39_Cum Cumulative Second Booster Dose Age 30 to 39

AD2_Age40to49_Cum Cumulative Second Booster Dose Age 40 to 49

AD2_Age50to59_Cum Cumulative Second Booster Dose Age50 to 59

AD2_Age60to69_Cum Cumulative Second Booster Dose Age 60 to 69

AD2_Age70to79_Cum Cumulative Second Booster Dose Age 70 to 79

AD2_Age80+_Cum Cumulative Second Booster Dose Age 80+

AD2_NA_Cum Cumulative Second Booster Dose Age Not Assigned

Booster2Per_Age05to11 Second Booster Percent Age 5 to 11 Cumulative Second Booster Age cohort/ Age cohort population

Booster2Per_Age12to19 Second Booster Percent  Age 10 to 19 Cumulative Second BoosterAge cohort/ Age cohort population

Booster2Per_Age20to29 Second Booster Percent  Age 20 to 29 Cumulative Second BoosterAge cohort/ Age cohort population

Booster2Per_Age30to39 Second Booster Percent  Age 30 to 39 Cumulative Second BoosterAge cohort/ Age cohort population

Booster2Per_Age40to49 Second Booster Percent  Age 40 to 49 Cumulative Second BoosterAge cohort/ Age cohort population

Booster2Per_Age50to59 Second Booster Percent Age 50 to 59 Cumulative Second BoosterAge cohort/ Age cohort population

Booster2Per_Age60to69 Second Booster Percent  Age 60 to 69 Cumulative Second BoosterAge cohort/ Age cohort population

Booster2Per_Age70to79 Second Booster Percent  Age 70 to 79 Cumulative Second BoosterAge cohort/ Age cohort population

Booster2Per_Age80+ Second Booster Percent  80+ Cumulative Second BoosterAge cohort/ Age cohort population

Booster2Per_NA Second Booster Percent  Not Assigned Cumulative Second BoosterAge cohort/ Age cohort population

Data Resources (6)

HTML
ArcGIS Hub Dataset
ARCGIS GEOSERVICES REST API
ArcGIS GeoService
GEOJSON
GeoJSON

Data Resource Preview - GeoJSON

Contact Person OSI
Contact Person Email customer.services@osi.ie
Contact Person Telephone -
Theme Health
Date released 2021-11-02
Date updated 2022-08-29
Language English
Landing page https://opendata-geohive.hub.arcgis.com/maps/2a4814b66d0d459cbb80dea30f61fbfe_0

Comments [0 ]


Be the first to comment